Skip to main content
OpenTrials

Clinical trial condition

Peripheral Vascular Diseases

Explore clinical trials studying Peripheral Vascular Diseases. Study availability and eligibility vary by location and protocol.

1,131 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Peripheral Vascular Diseases trial results

Completed

Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

NCT05007925

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +5 more
Locations
  • UCSF Fresno Fresno, California, United States
  • Scripps Memorial Hospital La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford Hospital Palo Alto, California, United States
View all 43 locations
View Trial Details
Completed

Shockwave IVL + DES

NCT05291247

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +11 more
Locations
  • SRH Klinikum Karlsbad-Langensteinbach Baden-Baden, Baden-Wurttemberg, Germany
  • University Hospital LMU Munich Munich, Bavaria, Germany
  • University Hospital Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Klinikum Hochsauerland Arnsberg, North Rhine-Westphalia, Germany
View Trial Details
Completed

Improve PAD PERformance With METformin

NCT03054519

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +5 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Tulane University New Orleans, Louisiana, United States
View Trial Details
Completed

Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

NCT05192941

Conditions
Angina Pectoris, Arterial Occlusive Diseases, Arteriosclerosis, +18 more
Locations
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Burgas, Bulgaria
  • Novartis Investigative Site Burgas, Bulgaria
  • Novartis Investigative Site Gabrovo, Bulgaria
View all 136 locations
View Trial Details

Related conditions